DCF — THE NEUROMEDICAL CENTER
Enterprise Value: $11.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$11.8M
Enterprise Value
$3.2M
PV of Cash Flows
$8.6M
PV of Terminal Value
$13.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $10.5M | $1.4M | 13.0% | $0.7M | $0.6M |
| Year 2 | $10.9M | $1.6M | 14.0% | $0.8M | $0.7M |
| Year 3 | $11.2M | $1.7M | 15.0% | $0.9M | $0.7M |
| Year 4 | $11.5M | $1.8M | 16.0% | $1.0M | $0.7M |
| Year 5 | $11.9M | $1.9M | 16.0% | $1.0M | $0.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $11.8M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$10.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.1297707400995007
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5